Compare IBEX & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBEX | NPCE |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.7M | 432.3M |
| IPO Year | 2017 | 2021 |
| Metric | IBEX | NPCE |
|---|---|---|
| Price | $29.13 | $15.54 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $35.00 | $18.33 |
| AVG Volume (30 Days) | 109.7K | ★ 165.9K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.26 | ★ 29.03 |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $558,273,000.00 | $99,986,000.00 |
| Revenue This Year | $14.13 | $0.90 |
| Revenue Next Year | $5.68 | $24.46 |
| P/E Ratio | $17.59 | ★ N/A |
| Revenue Growth | 9.77 | ★ 25.13 |
| 52 Week Low | $22.63 | $7.56 |
| 52 Week High | $42.99 | $18.97 |
| Indicator | IBEX | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 58.58 | 62.85 |
| Support Level | $27.36 | $15.25 |
| Resistance Level | $30.38 | $15.71 |
| Average True Range (ATR) | 0.82 | 0.67 |
| MACD | 0.36 | 0.22 |
| Stochastic Oscillator | 99.71 | 92.94 |
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.